Showing results (1-10 of 36) with videos related to
Sort By:
Pageof 4
Cancer Discovery|June 2, 2023
Bridging the Gap between Diseases of the Stomach and Lower EsophagusMatthew D StachlerCancer Cell|November 10, 2020
Can Genomic Sequencing Identify High-Risk Barrett's Esophagus Earlier Than Pathologists?Matthew D Stachler, Adam J BassSurgical Pathology Clinics|August 10, 2021
Molecular Pathology of Gastroesophageal CancerMatthew D Stachler, Ramon U JinVisceral Medicine|July 11, 2022
Today's Mistakes and Tomorrow's Wisdom in Development and Use of Biomarkers for Barrett's EsophagusNicola F Frei, Matthew D StachlerClinics in Laboratory Medicine|May 31, 2024
Molecular Pathology of Gastroesophageal CancerMatthew D Stachler, Ramon U JinThe American Journal of Gastroenterology|February 12, 2026
Biomarker Use in Barrett's Esophagus SurveillanceAnnesha Chatterjee, Julian A Abrams, Matthew D StachlerBMJ Oncology|January 31, 2025
Does radiofrequency ablation of the lower oesophagus allow for clonal expansion of highly mutated neosquamous epithelium?Fahire Goknur Akarca, Nicholas J Shaheen, Matthew D StachlerOncotargets and Therapy|August 16, 2023
Interleukin-33 as a Potential Therapeutic Target in Gastric Cancer Patients: Current InsightsAnnesha Chatterjee, Jordana Maria Azevedo-Martins, Matthew D StachlerApplied Immunohistochemistry & Molecular Morphology : AIMM|June 13, 2015
PIK3CA Mutations are Common in Many Tumor Types and are Often Associated With Other Driver MutationsMatthew D Stachler, Elizabeth M Rinehart, Elizabeth Garcia, et al.Expert Review of Molecular Diagnostics|October 23, 2018
Biomarkers for Barrett's esophagus - a contemporary reviewAlia P Qureshi, Matthew D Stachler, Omar Haque, et al.Pageof 4